Potential drug interactions in patients with sepsis admitted to the intensive care unit;Potenciales interacciones medicamentosas en pacientes con sepsis internados en la unidad de terapia intensiva

Farmacia Hospitalaria

Volumn 37, Issue 5, 2013, Pages 383-387

  Caribe R A ^a   Chaves, G R ^b   Pocognoni, J D ^c   Souza, I A ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Rua Desembargador Virgílio de Sá Pereira ^*  (Brazil)

^c Hospital El Sauce   (Argentina)

Author keywords

Drug interactions; Intensive care units; Sepsis

Indexed keywords

ARTICLE; DRUG INTERACTION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; SEPSIS;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; BRAZIL; CROSS INFECTION; DRUG INTERACTIONS; DRUG PRESCRIPTIONS; DRUG SYNERGISM; FEMALE; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK; RISK MANAGEMENT; SEPSIS;

EID: 84887844561     PISSN: 11306343     EISSN: 21718695     Source Type: Journal    
DOI: 10.7399/FH.2013.37.5.534     Document Type: Article

References (23)

1. Hammmes JA, Pfuetzenreiter, Silveira F, Koeing A, Wesohal GA. Prevalência de potenciais interações medicamentosas droga-droga em unidades de terapia intensiva. Rev Bras Ter Intensiva. 2008; 20(4):354-9.
2. Lima REF, Cassiani SHB. Interações medicamentosas potenciais em pacientes de unidade de terapia intensiva de um hospital universitário. Rev Lat Am Enfermagem. 2009 Mar-Abr;17(2):222-7.
3. Juurlink DN, Muhammad M, Kopp A, Laupacis A, Redelmeier DA. Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity. JAMA. 2003;289(13):1652-8.
4. Leape LL, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995;274(1):35-43.
5. Rivkin A, Yin H. Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients. J Crit Care. 2011 Feb;26(1):104.e1-e6.
6. Júnior FP, Godoy DB, Pires DFS, Pietrobon E, Rosa FTA, Saraiva JS, et al. Potenciais interações medicamentosas em prescrições de um hospital-escola de Porto Alegre. Rev Assoc Med Rio Grande Do Sul. 2009 Jul-Set;53(3):251-6.
7. Silva E, Pedro MA, Sogayar ACB, Mohovic T, Silva CLO, Janiszewski M, et al. Brazilian Sepsis Epidemiological Study (BASES study). Crit Care; 2004 Aug;8(4):R251-60.
8. Micromedex® Healthcare Series (electronic version). Thomson Micromedex, Greenwood Village, Colorado, USA [Citado 05-11-2012]. Disponible en: http://www.thomsonhc.com.
9. World Health Organization (WHO). Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment, 2012. [Citado 01-10-2012]. Disponible en: http://www.whocc.no/atc-ddd-publications/ guidelines
10. Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci. 2006;9(3):427-33.
11. Sehn R, Camargo AL, Heineck I, Ferreira MBC. Interações medicamentosas potenciais em prescrições de pacientes hospitalizados. Infarma. 2003 Set-Out;15(9-10):77-81.
12. Rossignoli PS, Guarido CF, Cestari IM. Ocorrência de interações medicamentosas em Unidades de Terapia Intensiva: avaliação de prescrições médicas. Rev Bras Farm. 2006;87(4):104-7.
13. Reis AMM, Cassiani SHB. Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil. Clinics. 2011;66(1):9-15.
14. Meinrs MMMa, Bergsten-Mendes G. Prescrição de medicamentos para crianças hospitalizadas: como avaliar a qualidade? Rev Ass Med Bras. 2001;47(4):332-7.
15. Janchawee B, Wongpoowarak W, Owatranporn T, Chongsuvivatwongs V. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. Int J Clin Pharm. 2005;30(1):13-20.
16. Buc a C, Farc a A, Cazacu I, Leucuta D, Achimas-Cadariu A, Mogosan C, et al. How many potential drug-drug interactions cause adverse drug reactions in hospitalized patients? [consultado 09/11/2012]. Disponible en: http://dx.doi.org/10.1016/j.bbr.2011. 03.031
17. Vonbach P, Dubied A, Krähenbühl S, Beer JH. Prevalence of drugdrug interactions at hospital entry and during hospital stay of patients in internal medicine. Eur J Intern Med. 2008;19:413-20.
18. Malone DC, Abarca J, Hansten PD, Grizzle AJ. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc. 2004;44(2):142-51.
19. Albánez A, Alcalá M, García J, Puche E. Interacciones medicamentosas en pacientes de un servicio de medicina interna. Farm Hosp. 2008:32(5):293-7.
20. Hansten, PD. Drug interaction management. Pharm World Sci. 2003 Jun;25(3)94-7.
21. Devlin JW, Roberts RJ. Pharmacology of commonly used analgesic and sedatives in the ICU: benzodiazepines, propofol and opioids. Crit Care Clin. 2009 Jul;25(3):431-49.
22. Devlin JW. The pharmacology of oversedation in mechanically ventilated adults. Curr Opin Crit Care. 2008 Aug;14(4):403-7.
23. Riker RR, Fraser GL. Altering intensive care sedation paradigms to improve patient outcomes. Crit Care Clin. 2009 Jul;25(3):527-38.